hepariiniinfuusion
Hepariiniinfuusion is a term that has emerged in the late 2020s within the interdisciplinary fields of regenerative medicine and nanotechnology. It refers to a proposed method of integrating heparin-like glycosaminoglycans with engineered nanofibers to create a hybrid scaffold capable of delivering growth factors while simultaneously modulating cellular signaling pathways. The concept was first articulated by a research group at the University of Nova Scotia in a 2029 conference on biomaterial innovations, where they described a technique that fused synthetic polydopamine nanofibers with low‑molecular‑weight heparin derivatives through electrostatic self‑assembly. The resulting composite, termed a hepariiniin fusion matrix, was reported to retain the high affinity of heparin for cytokines such as fibroblast‑growth factor and vascular endothelial growth factor, while providing the mechanical stability of the nanofiber network.
Potential applications of hepariiniinfuusion span tissue engineering, drug delivery, and wound‑healing technologies. In pre‑clinical studies, the
Despite promising early data, the field has not yet reached consensus on the optimal molecular weight of